174 related articles for article (PubMed ID: 28602702)
1. The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in adults.
Murdoch F; Danial J; Morris AK; Czarniak E; Bishop JL; Glass E; Imrie LJ
J Hosp Infect; 2017 Oct; 97(2):133-139. PubMed ID: 28602702
[TBL] [Abstract][Full Text] [Related]
2. The Scottish enhanced Staphylococcus aureus bacteraemia surveillance programme: the first 18 months of data in children.
Murdoch F; Danial J; Morris AK; Czarniak E; Bishop JL; Glass E; Imrie LJ
J Hosp Infect; 2017 Oct; 97(2):127-132. PubMed ID: 28645466
[TBL] [Abstract][Full Text] [Related]
3. Enhanced surveillance of Staphylococcus aureus bacteraemia to identify targets for infection prevention.
Morris AK; Russell CD
J Hosp Infect; 2016 Jun; 93(2):169-74. PubMed ID: 27107617
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
[TBL] [Abstract][Full Text] [Related]
5. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
Kok J; O'Sullivan MV; Gilbert GL
J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
[TBL] [Abstract][Full Text] [Related]
6. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
7. Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates.
Khatib R; Sharma M; Iyer S; Fakih MG; Obeid KM; Venugopal A; Fishbain J; Johnson LB; Segireddy M; Jose J; Riederer K
Am J Infect Control; 2013 Mar; 41(3):210-3. PubMed ID: 23040608
[TBL] [Abstract][Full Text] [Related]
8. Morbidity and mortality of Staphylococcal bacteremia in children.
Hakim H; Mylotte JM; Faden H
Am J Infect Control; 2007 Mar; 35(2):102-5. PubMed ID: 17327189
[TBL] [Abstract][Full Text] [Related]
9. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
10. Low mortality of Staphylococcus aureus bacteremia in Icelandic children: nationwide study on incidence and outcome.
Asgeirsson H; Gudlaugsson O; Kristinsson KG; Vilbergsson GR; Heiddal S; Haraldsson A; Weiland O; Kristjansson M
Pediatr Infect Dis J; 2015 Feb; 34(2):140-4. PubMed ID: 24992124
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review.
Denniston S; Riordan FA
J Infect; 2006 Dec; 53(6):387-93. PubMed ID: 16476482
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality.
Asgeirsson H; Gudlaugsson O; Kristinsson KG; Heiddal S; Kristjansson M
Clin Microbiol Infect; 2011 Apr; 17(4):513-8. PubMed ID: 20491831
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired Staphylococcus aureus bacteremia: Studies of risk and prognosis with special attention to diabetes mellitus and chronic heart failure.
Smit J
Dan Med J; 2017 May; 64(5):. PubMed ID: 28552097
[TBL] [Abstract][Full Text] [Related]
14.
Jaganath D; Jorakate P; Makprasert S; Sangwichian O; Akarachotpong T; Thamthitiwat S; Khemla S; DeFries T; Baggett HC; Whistler T; Gregory CJ; Rhodes J
Am J Trop Med Hyg; 2018 Jul; 99(1):155-163. PubMed ID: 29761760
[No Abstract] [Full Text] [Related]
15. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality.
Hill PC; Birch M; Chambers S; Drinkovic D; Ellis-Pegler RB; Everts R; Murdoch D; Pottumarthy S; Roberts SA; Swager C; Taylor SL; Thomas MG; Wong CG; Morris AJ
Intern Med J; 2001 Mar; 31(2):97-103. PubMed ID: 11480485
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of community-acquired and health care-associated Staphylococcus aureus bacteremia in patients treated at the emergency department of a teaching hospital.
Liao CH; Chen SY; Chang SC; Hsueh PR; Hung CC; Chen YC
Diagn Microbiol Infect Dis; 2005 Oct; 53(2):85-92. PubMed ID: 16168612
[TBL] [Abstract][Full Text] [Related]
17. Thirty-day mortality in UK patients with community-onset and hospital-acquired meticillin-susceptible Staphylococcus aureus bacteraemia.
Melzer M; Welch C
J Hosp Infect; 2013 Jun; 84(2):143-50. PubMed ID: 23602415
[TBL] [Abstract][Full Text] [Related]
18. Trends in incidence and resistance patterns of Staphylococcus aureus bacteremia
Jokinen E; Laine J; Huttunen R; Lyytikäinen O; Vuento R; Vuopio J; Syrjänen J
Infect Dis (Lond); 2018 Jan; 50(1):52-58. PubMed ID: 29161942
[TBL] [Abstract][Full Text] [Related]
19. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study.
Gotland N; Uhre ML; Mejer N; Skov R; Petersen A; Larsen AR; Benfield T;
J Infect; 2016 Oct; 73(4):346-57. PubMed ID: 27418382
[TBL] [Abstract][Full Text] [Related]
20. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review.
Robinson JO; Pearson JC; Christiansen KJ; Coombs GW; Murray RJ
Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):353-61. PubMed ID: 18850122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
